<H1>Chapter DOI: 10.1208/aapsj070229<br/>Cited-By Count: 14</H1><table border="1" width="30%"><tr><td>Total References</td><td>35</td></tr><tr><td>Springer references</td><td>4</td></tr><tr><td>Non Springer references</td><td>31</td></tr><tr><td>BibStructured Count</td><td width="10%">32</td></tr><tr><td>BibUnstructured Count</td><td width="10%">3</td></tr><tr><td>DOI already available in SpringerLink</td><td>20</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>1</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>1</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>1</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibChapter</td><td>United States Pharmacopeial Convention. Good compounding practices. In:<Emphasis Type="Italic">The United States Pharmacopeia and the National Formulary, USP 28, NF 23</Emphasis>. Rockville, MD: United States Pharmacopeial Convention, Inc; 2005:2620&#8211;2457.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibArticle</td><td>FDA-CVM. FDA/CVM's Compliance policy guide on compounding of drugs.<Emphasis Type="Italic">J. Am Vet Med Assoc.</Emphasis> 1996;209:2025&#8211;2029.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibUnstructured</td><td>Symposium on Compounding in Veterinary Medicine. <span style='background:#CCFF99'><i>J Am Vet Med Assoc</i></span>. <span style='background:#66FF66'>1993</span>;<span style='background:#FFCC66'>205</span>:<span style='background:#D279FF'>189&#8211;303</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR4</td><td>BibUnstructured</td><td><span style='background:#BDBAD6'>FDA-CVM. Food and Drug Administration Web site. Compounding of Drugs for Use in Animals. Compliance Policy Guide</span>: <span style='background:#FFD9B3'>Compliance Policy Guidance for FDA Staff and Industry</span>. Ch 6, sub ch 600, &#167;608.400. <span style='background:#FFFF0F'>Available at: http://www.fda.gov/cvm/index/updates/compound.htm. Accessed July 2003</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>JAVMA. Animal drugs seized.<Emphasis Type="Italic">J Am Vet Med Assoc</Emphasis>. 1999;214:21.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Davis J. Compounding for creatures: what works.<Emphasis Type="Italic">Int J Pharm Comp</Emphasis>. 1999;3:182&#8211;187.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Graham JP, Lipman AH, Newell SM, Roberts GD. Esophageal transit of capsules in clinically normal cats.<Emphasis Type="Italic">Am J Vet Res.</Emphasis> 2000;61:655&#8211;657.</td><td><a href=http://dx.doi.org/10.2460/ajvr.2000.61.655>10.2460/ajvr.2000.61.655</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Westfall DS, Twedt DC, Steyn PF., Oberhauser EB, VanCleave JW. Evaluation of esophageal transit of tablets and capsules in 30 cats.<Emphasis Type="Italic">J Vet Intern Med.</Emphasis> 2001;15:467&#8211;470.</td><td><a href=http://dx.doi.org/10.1892/0891-6640(2001)015&lt;0467:EOETOT&gt;2.3.CO;2>10.1892/0891-6640(2001)015&lt;0467:EOETOT&gt;2.3.CO;2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Carlborg B, Densert O. Esophageal lesions caused by orally administered drugs: an experimental study in the cat.<Emphasis Type="Italic">Eur Surg Res.</Emphasis> 1980;12:270&#8211;282.</td><td><a href=http://dx.doi.org/10.1159/000128132>10.1159/000128132</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, FirstPage, Author_FamilyName_2, VolumeID, Author_FamilyName_1, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Carlborg B, Densert O, Lindqvist C. Tetracycline induced esophagcal ulcers: a clinical and experimental study.<Emphasis Type="Italic">Laryngoscope</Emphasis>. 1983;93:184&#8211;187.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR11</td><td>BibChapter</td><td>United States Pharmacopeial Convention. Stability considerations in dispensing practice. In:<Emphasis Type="Italic">The United States Pharmacopeia and the National Formulary, USP 28, NF 23</Emphasis>. Rockville, MD: United States Pharmacopeial Convention, Inc; 2005:2727&#8211;2730.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Nieto JE, Spier S, Pipers FS, et al., Comparison of paste and suspension formulations of omeprazole in the healing of gastric ulcers in racehorses in active training.<Emphasis Type="Italic">J Am Vet Med Assoc</Emphasis>, 2002;221:1139&#8211;1143.</td><td><a href=http://dx.doi.org/10.2460/javma.2002.221.1139>10.2460/javma.2002.221.1139</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Grass GM, Sinko PJ. Physiologically-based pharmacokinetic simulation modelling.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2002;54:433&#8211;451.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(02)00013-3>10.1016/S0169-409X(02)00013-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Martinez M, Amidon G, Clarke L, Jones WW, Mitra A, Riviere J. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2002;54:825&#8211;850.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(02)00071-6>10.1016/S0169-409X(02)00071-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Martinez M, Augsburger L, Johnston T, Jones WW. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I. Biopharmaceutics and formulation considerations.<Emphasis Type="Italic">Adv Drug Deliv Rev.</Emphasis> 2002:54:805&#8211;824.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(02)00070-4>10.1016/S0169-409X(02)00070-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of<Emphasis Type="Italic">in vitro</Emphasis> drug product dissolution and<Emphasis Type="Italic">in vivo</Emphasis> bioavailability.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1995;12:413&#8211;420.</td><td><a href=http://dx.doi.org/10.1023/A:1016212804288>10.1023/A:1016212804288</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Kararli TT. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.<Emphasis Type="Italic">Biopharm Drug Dispos</Emphasis>. 1995;16:351&#8211;380.</td><td><a href=http://dx.doi.org/10.1002/bdd.2510160502>10.1002/bdd.2510160502</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Dressman JB. Comparison of canine and human gastrointestinal physiology.<Emphasis Type="Italic">Pharm Res.</Emphasis> 1986;3:123&#8211;131.</td><td><a href=http://dx.doi.org/10.1023/A:1016353705970>10.1023/A:1016353705970</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Lin JH. Species similarities and differences in pharmacokinetics.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1995;23:1008&#8211;1021.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Chiou WL, Jeong HY, Chung SM, Wu TC. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans.<Emphasis Type="Italic">Pharm Res</Emphasis>. 2000;17:135&#8211;140.</td><td><a href=http://dx.doi.org/10.1023/A:1007552927404>10.1023/A:1007552927404</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Sabnis S. Factors influencing the bioavailability of peroral formulations of drugs for dogs.<Emphasis Type="Italic">Vet Res Commun</Emphasis>. 1999;23:425&#8211;447.</td><td><a href=http://dx.doi.org/10.1023/A:1006321625243>10.1023/A:1006321625243</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Lee DD, Papich MG, Hardie EM. Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats.<Emphasis Type="Italic">Am J Vet Res.</Emphasis> 2000;61:672&#8211;677.</td><td><a href=http://dx.doi.org/10.2460/ajvr.2000.61.672>10.2460/ajvr.2000.61.672</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Kyles AE, Papich MG, Hardie EM. Disposition of transdermally administered fentanyl in dogs.<Emphasis Type="Italic">Am J Vet Res</Emphasis>. 1996;57:715&#8211;719.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Kyles AE, Hardie EM, Hansen BD, Papich MG Comparison of transdermal fentanyl and intramuscular oxymorphone on post-operative behaviour after ovariohysterectomy in dogs.<Emphasis Type="Italic">Res Vet Sci</Emphasis>. 1998;65:245&#8211;251.</td><td><a href=http://dx.doi.org/10.1016/S0034-5288(98)90151-5>10.1016/S0034-5288(98)90151-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Riviere JE, Papich MG. Potential, and problems of developing transdermal patches for veterinary applications.<Emphasis Type="Italic">Adv Drug Deliv Rev</Emphasis>. 2001;50:175&#8211;203.</td><td><a href=http://dx.doi.org/10.1016/S0169-409X(01)00157-0>10.1016/S0169-409X(01)00157-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibBook</td><td>Nolan TR, Davidson G, Webster K, Pharmacokinetics of transdermal diltiazem in cats [abstract 25]. Paper presented at: North Carolina State Research Forum; May 2002; North Carolina State University, Raleigh, NC.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.<Emphasis Type="Italic">J Vet Pharmacol Therap</Emphasis>. 2002;25:189&#8211;193.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2885.2002.00405.x>10.1046/j.1365-2885.2002.00405.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Bennett N, Papich MG, Hoenig M, Fettman MJ, Lappin MR. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats.<Emphasis Type="Italic">Am J Vet Res</Emphasis>. 2005;66:581&#8211;588.</td><td><a href=http://dx.doi.org/10.2460/ajvr.2005.66.581>10.2460/ajvr.2005.66.581</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Ciribassi J, Luescher A, Pasloske KS, Robertson-Plouch C, Zimmerman A, Kaloostian-Whittymore L. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.<Emphasis Type="Italic">Am J Vet Res</Emphasis>. 2003;64:994&#8211;998.</td><td><a href=http://dx.doi.org/10.2460/ajvr.2003.64.994>10.2460/ajvr.2003.64.994</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Trepanier</span> <span style='background:#DDDDDD'>LA</span></span></aug>. Transdermal formulations: which ones are effective? ACVIM Annual Forum Proceedings; June <span style='background:#66FF66'>2002</span>; American College of Veterinary Medicine. <span style='background:#D279FF'>463&#8211;464</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Sartor LL, Trepanier LA, Kroll MM, Rodan I, Challoner L. Efficacy and safety of transdermal methimazole in the treatment of cats with hyperthyroidism.<Emphasis Type="Italic">J Vet Intern Med</Emphasis>. 2004.18(5):651&#8211;655.</td><td><a href=http://dx.doi.org/10.1892/0891-6640(2004)18&lt;651:EASOTM&gt;2.0.CO;2>10.1892/0891-6640(2004)18&lt;651:EASOTM&gt;2.0.CO;2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Hoffman G, Marks SL, Taboada J, et al. Topical methimazole treatment of cats with hyperthyroidism.<Emphasis Type="Italic">J Vet Intern Med</Emphasis>. 2001;15:299.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Mealey KL, Peck KE, Bennett BS, et al. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.<Emphasis Type="Italic">J Vet Intern Med</Emphasis>. 2004; 18(1):43&#8211;46.</td><td><a href=http://dx.doi.org/10.1892/0891-6640(2004)18&lt;43:SAOAAB&gt;2.0.CO;2>10.1892/0891-6640(2004)18&lt;43:SAOAAB&gt;2.0.CO;2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Willis-Goulet HS, Schmidt BA, Nicklin CF, et al. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.<Emphasis Type="Italic">Vet Dermatol</Emphasis>. 2003;14:83&#8211;89.</td><td><a href=http://dx.doi.org/10.1046/j.1365-3164.2003.00331.x>10.1046/j.1365-3164.2003.00331.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibChapter</td><td>United States Pharmacopeial Convention. Pharmaceutical compounding. In: The United States Pharmacopeia and the National Formulary, USP 28, NF 23. Rockville, MD: United States Pharmacopeial Convention Inc; 2005:&lt;795&gt;, &lt;797&gt;,&lt;1075&gt;.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></table>